The FDA is now mandating GLP-1 weight loss drugs carry a warning label that the medications carry “a potential increased risk” of a rare eye condition that may cause permanent vision loss. The FDA is now mandating GLP-1 weight loss drugs carry a warning label that the medications carry “a potential increased risk” of a rare eye condition that may cause permanent vision loss.
FDA Orders Warning Label on GLP-1s for Risk of Eye ConditionFDA Orders Warning Label on GLP-1s for Risk of Eye Condition
